Figure S2 from Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer
Year: 2026
Type: other
Abstract: Distribution of biomarker levels for benign and malignant pulmonary nodules in the Train (A, n=371, 54% malignant) and Test (B, n=166, 44% malignant) cohorts. Brackets show the corresponding p value statistic for the t-test by biomarker.
Authors: Kevin Connor McGann, Palina Woodhouse, Heidi Chen, Michael N. Kammer, Hudson Michael Holmes, Camden Lopez, Harvey I. Pass, Jun-Chieh J. Tsay, Marc E. Lenburg, Steven M. Dubinett, James C. Willey, James G. Herman, Matthew B. Schabath, Timothy A. Khalil, Yong Zou, Melissa H. Potter, Sheau-Chiann Chen, Samson A. Argaw, Patrick Meyers, Sam Fischer, Carolyn Tran, Yency J. Forero, Sanja Antic, Rafael Paez, Eardi Lila, Anna E. Barón, Fabien Maldonado, Stephen A. Deppen, Eric L. Grogan
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7166865362
Cites:
Cited by:
Related to: